Pyroptosis of syncytia formed by fusion of SARS-CoV-2 spike and ACE2-expressing cells
Open Access
- 24 August 2021
- journal article
- letter
- Published by Springer Nature in Cell Discovery
- Vol. 7 (1) , 1-4
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (81700596, 91856126, 81630042)
This publication has 18 references indexed in Scilit:
- Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2American Journal of Respiratory and Critical Care Medicine, 2020
- Site-specific glycan analysis of the SARS-CoV-2 spikeScience, 2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusionCell Research, 2020
- A new coronavirus associated with human respiratory disease in ChinaNature, 2020
- A pneumonia outbreak associated with a new coronavirus of probable bat originNature, 2020
- Single-Cell Transcriptomic Analysis of Human Lung Provides Insights into the Pathobiology of Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2019
- Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasderminNature, 2017
- Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic/pyroptotic cell deathNature Communications, 2017
- The Genotype-Tissue Expression (GTEx) ProjectBiopreservation and Biobanking, 2015